MetLife Investment Management, LLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 176 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.7%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$133,197
-36.2%
42,0180.0%0.00%
-50.0%
Q2 2023$208,829
+0.6%
42,0180.0%0.00%0.0%
Q1 2023$207,569
-21.5%
42,0180.0%0.00%0.0%
Q4 2022$264,293
-41.8%
42,0180.0%0.00%
-50.0%
Q3 2022$453,794
-1.3%
42,018
+4.1%
0.00%0.0%
Q2 2022$459,990
+39.0%
40,350
+11.1%
0.00%
+100.0%
Q1 2022$330,930
-3.2%
36,326
+58.6%
0.00%
-33.3%
Q4 2021$341,772
-41.9%
22,9070.0%0.00%
-40.0%
Q3 2021$588,710
-1.5%
22,9070.0%0.01%
-16.7%
Q2 2021$597,415
-26.1%
22,9070.0%0.01%
-25.0%
Q1 2021$808,617
+39.9%
22,9070.0%0.01%
+33.3%
Q4 2020$578,173
-33.1%
22,9070.0%0.01%
-33.3%
Q3 2020$863,823
-6.4%
22,907
+6.3%
0.01%
-10.0%
Q2 2020$923,028
+163.7%
21,556
+19.7%
0.01%
+100.0%
Q1 2020$350,095
-25.2%
18,0090.0%0.01%0.0%
Q4 2019$467,874
-4.7%
18,0090.0%0.01%
-16.7%
Q3 2019$490,835
+1.5%
18,0090.0%0.01%
+20.0%
Q2 2019$483,539
+32.4%
18,009
+42.5%
0.01%
+25.0%
Q1 2019$365,307
+7.4%
12,6360.0%0.00%0.0%
Q4 2018$340,28712,6360.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$26,829,00010.04%
Wildcat Capital Management, LLC 1,716,370$25,608,0004.17%
TPG GP A, LLC 18,716,306$279,247,0002.79%
Casdin Capital, LLC 2,650,000$39,538,0001.11%
Lombard Odier Asset Management (Switzerland) SA 996,116$14,862,0000.95%
Coastal Bridge Advisors, LLC 301,929$4,505,0000.94%
HARBOR CAPITAL ADVISORS, INC. 119,547$1,784,0000.65%
Pier Capital, LLC 294,968$4,401,0000.46%
Navalign, LLC 64,428$961,0000.38%
Gratus Capital, LLC 191,871$2,863,0000.26%
View complete list of ALLOGENE THERAPEUTICS INC shareholders